Hot Topics

Model N Moves To New Offices In Silicon Valley And Waltham, Mass.

Model N, Inc. (NYSE:MODN), the leading provider of cloud-based revenue management solutions to life sciences, technology and manufacturing companies, today announced its move to new offices in San Mateo, Calif.

Model N, Inc. (NYSE:MODN), the leading provider of cloud-based revenue management solutions to life sciences, technology and manufacturing companies, today announced its move to new offices in San Mateo, Calif., and Waltham, Mass.

The announcement, which follows a record quarterly and annual earnings report on November 7th, underscored both Model N's business momentum and commitment to attracting and retaining top talent.

"Model N is committed as ever to fostering a work environment that attracts, retains and develops extraordinary employees," said Zack Rinat, founder, chairman of the board and CEO of Model N. "As we complete the transition to 100% SaaS, we have located our new offices in the center of two of the most dynamic tech communities in the world."

"People are the secret to our success," said SVP and Chief People Officer, Amelia Generalis. "This move represents our commitment to providing them with the best possible work environment to innovate in, and it positions us to be even more competitive as we attract new talent."

The new offices are located close to regional transportation hubs, and both feature open floor plans and collaborative workspaces.

About Model N

Model N is the leader in revenue management solutions. Driving mission-critical business processes such as configure, price and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance, Model N solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the complex business needs of the world's leading brands in life sciences, technology and manufacturing across more than 120 countries, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis and Microchip Technology. For more information, visit www.modeln.com

Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.